Literature DB >> 2888136

Self-administration of barbiturates and benzodiazepines: a review.

N A Ator, R R Griffiths.   

Abstract

Studies of barbiturate and benzodiazepine self-administration are categorized by species and route of administration. Reinforcement, defined as self-administration of drug greater than of a non-drug control, has been demonstrated most often in studies employing the IV route, and there has been greater reliability in this result for a given drug among barbiturates rather than among benzodiazepines. Most studies of PO self-administration in rodents have not demonstrated reinforcement, despite a number of behavioral manipulations to induce drug intake. Studies of PO barbiturate self-administration in monkeys have demonstrated reinforcement but recent studies of PO benzodiazepine self-administration in baboons have not, although physical dependence was demonstrated. Reinforcement via the IG route has not been reliably demonstrated. Behavioral variables, including interreinforcement interval and drug self-administration history, appear to be important determinants of whether or not reinforcement will be demonstrated, particularly among the benzodiazepines; but the range of conditions under which behavioral and pharmacological variables interact to promote or lessen the likelihood of self-administration of these drugs remains to be determined experimentally.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888136     DOI: 10.1016/0091-3057(87)90588-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  18 in total

Review 1.  Translational research in behavior analysis: historical traditions and imperative for the future.

Authors:  F Charles Mace; Thomas S Critchfield
Journal:  J Exp Anal Behav       Date:  2010-05       Impact factor: 2.468

2.  Effects of triazolam on drinking in baboons with and without an oral self-administration history: a reinstatement phenomenon.

Authors:  M A Kautz; N A Ator
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 3.  The evaluation of the abuse liability of drugs.

Authors:  C E Johanson
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

4.  Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure.

Authors:  H de Wit; J Pierri; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.

Authors:  Timothy W Lefever; Julie A Marusich; Kateland R Antonazzo; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2014-01-09       Impact factor: 3.533

Review 6.  Animal models of substance abuse and addiction: implications for science, animal welfare, and society.

Authors:  Wendy J Lynch; Katherine L Nicholson; Mario E Dance; Richard W Morgan; Patricia L Foley
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

7.  Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys.

Authors:  Jillian H Broadbear; Gail Winger; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2004-08-21       Impact factor: 4.530

8.  Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

10.  Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.

Authors:  Mei-Chuan Ko; James H Woods; William E Fantegrossi; Chad M Galuska; Jürgen Wichmann; Eric P Prinssen
Journal:  Neuropsychopharmacology       Date:  2009-03-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.